Bladder management, severity of injury and period of latency: a descriptive study on 135 patients with spinal cord injury and bladder cancer

Spinal Cord. 2021 Sep;59(9):971-977. doi: 10.1038/s41393-021-00651-3. Epub 2021 Jun 17.

Abstract

Study design: Longitudinal study.

Objectives: To describe the severity of spinal cord injury/disease (SCI/D), type and management of neurogenic lower urinary tract dysfunction, tumor characteristics, and bladder cancer latency period in SCI/D patients.

Setting: Spinal cord injury centers in Germany, Austria, and Switzerland.

Methods: Data of SCI/D patients diagnosed with bladder cancer were collected between Jan 2012-Dec 2019 in the course of annual surveys in the neuro-urological departments of all 28 centers. Demographic and paralysis-specific data, data on the type and management of neurogenic lower urinary tract dysfunction, and histopathological tumor characteristics were collected.

Results: Regarding histopathological tumor characteristics, no significant differences were found in 135 individuals with SCI/D when stratified for bladder management without chronic catheterization, SCI/D severity, and ASIA classification. The mean latency period between the onset of SCI/D and the diagnosis of bladder cancer was significantly longer in patients with catheter-free emptying methods compared to patients with intermittent catheterization, and in patients with LMNL (Lower Motor Neuron Lesion) compared to patients with UMNL (Upper Motor Neuron Lesion).

Conclusions: Urinary bladder carcinomas are late events in the long-term course of SCI/D. Follow-up and approaches to screening must therefore be intensified with increasing duration of long-term SCI.

MeSH terms

  • Humans
  • Longitudinal Studies
  • Spinal Cord Injuries* / complications
  • Spinal Cord Injuries* / epidemiology
  • Spinal Cord Injuries* / therapy
  • Urinary Bladder Neoplasms* / complications
  • Urinary Bladder Neoplasms* / epidemiology
  • Urinary Bladder Neoplasms* / therapy
  • Urinary Bladder, Neurogenic* / etiology
  • Urinary Bladder, Neurogenic* / therapy